Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Oncternal Therapeutics Inc. buy Brookline Capital Management

Oncternal Therapeutics Inc.
Start price
€0.70
11.03.23 / 50%
Target price
-
11.03.24
Performance (%)
-62.03%
End price
-
12.03.24
Summary
This prediction is currently being closed. Massive losses of -62.03% have been the result for the BUY prediction by Brookline_Capital_Ma. Brookline_Capital_Ma has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
Oncternal Therapeutics Inc. - - -
iShares Core DAX® 1.301% -1.386% 12.259%
iShares Nasdaq 100 0.612% -4.172% 1.687%
iShares Nikkei 225® 8.772% 9.777% 30.041%
iShares S&P 500 0.254% -2.301% 0.794%

Comments by Brookline_Capital_Ma for this prediction

In the thread Oncternal Therapeutics Inc. diskutieren

Oncternal Therapeutics, Inc. (NASDAQ: ONCT) had its "buy" rating re-affirmed by analysts at Brookline Capital Management.
Ratings data for ONCT provided by MarketBeat

Brookline Capital Management 
0
Report Share
11.03.23 Buy -62.03%
In the thread Trading Oncternal Therapeutics Inc.
Prediction Buy
Perf. (%) -62.03%
Target price
Change
Ends at 11.03.24

Die von Brookline_Capital_Ma gewählte maximale Laufzeit wurde überschritten

Brookline Capital Management 
0
Report Share
12.03.24

Stopped prediction by Brookline_Capital_Ma for Oncternal Therapeutics Inc.

buy
Oncternal Therapeutics Inc.

Start price
Target price
Perf. (%)
€0.31
04.12.23
€1.85
04.12.24
3.23%
05.12.24

Brookline Capital Management 
04.12.23 50%